1-14 of 14
Dario Neri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics

Available to Purchase
Matilde Bocci, Lucrezia Principi, Dario Neri, Samuele Cazzamalli, Ettore Gilardoni, Andrea Galbiati
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF10.
https://doi.org/10.1158/1535-7163.MCT-25-0026
Published: 14 July 2025
View article titled, Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics
Open the PDF for Development of Multivalent FAP-Targeted Small Molecule–Drug Conjugates with Tailored MMAE Release Kinetics in another window
Includes: Supplementary data
Journal Articles

PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer

Available to Purchase
Tony Georgiev, Sara Puglioli, Lucrezia Principi, Ettore Gilardoni, Christian Pellegrino, Gabriele Bassi, Andrea Galbiati, Dario Neri, Samuele Cazzamalli
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF9.
https://doi.org/10.1158/1535-7163.MCT-24-0750
Published: 21 March 2025
View article titled, PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
Open the PDF for PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer

Available to Purchase
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Zangger, Frederik Peissert, Stefanie K. Pfister, Christian Pellegrino, Sheila Dakhel Plaza, Roberto De Luca, Markus G. Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (7): 1010–1020.
https://doi.org/10.1158/1535-7163.MCT-23-0766
Published: 02 July 2024
View article titled, Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
Open the PDF for Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer in another window
Includes: Multimedia, Supplementary data
Journal Articles

Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade

Open Access
Andrea T. Hooper, Kimberly Marquette, Chao-Pei Betty Chang, Jonathon Golas, Sadhana Jain, My-Hanh Lam, Magali Guffroy, Mauricio Leal, Hadi Falahatpisheh, Divya Mathur, Ting Chen, Kerry Kelleher, Kiran Khandke, Elwira Muszynska, Frank Loganzo, Edward Rosfjord, Judy Lucas, Zhengyan Kan, Chakrapani Subramanyam, Christopher O'Donnell, Dario Neri, Hans-Peter Gerber, Chad May, Puja Sapra
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (9): 1462–1472.
https://doi.org/10.1158/1535-7163.MCT-22-0099
Published: 06 September 2022
View article titled, Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade
Open the PDF for Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade in another window
Includes: Supplementary data
Journal Articles

A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis

Available to Purchase
Riccardo Corbellari, Marco Stringhini, Jaqueline Mock, Tiziano Ongaro, Alessandra Villa, Dario Neri, Roberto De Luca
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (5): 859–871.
https://doi.org/10.1158/1535-7163.MCT-20-0853
Published: 01 May 2021
View article titled, A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis
Open the PDF for A Novel Antibody–IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis in another window
Includes: Supplementary data
Journal Articles

Immunotherapy with Immunocytokines and PD-1 Blockade Enhances the Anticancer Activity of Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX

Available to Purchase
Jacopo Millul, Christiane Krudewig, Aureliano Zana, Sheila Dakhel Plaza, Emanuele Puca, Alessandra Villa, Dario Neri, Samuele Cazzamalli
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (3): 512–522.
https://doi.org/10.1158/1535-7163.MCT-20-0361
Published: 02 March 2021
View article titled, Immunotherapy with Immunocytokines and PD-1 Blockade Enhances the Anticancer Activity of Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX
Open the PDF for Immunotherapy with Immunocytokines and PD-1 Blockade Enhances the Anticancer Activity of Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in another window
Includes: Supplementary data
Journal Articles

An Antibody-Tumor Necrosis Factor Fusion Protein that Synergizes with Oxaliplatin for Treatment of Colorectal Cancer

Available to Purchase
Davor Bajic, Kerry Chester, Dario Neri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (12): 2554–2563.
https://doi.org/10.1158/1535-7163.MCT-19-0729
Published: 02 December 2020
View article titled, An Antibody-Tumor Necrosis Factor Fusion Protein that Synergizes with Oxaliplatin for Treatment of Colorectal Cancer
Open the PDF for An Antibody-Tumor Necrosis Factor Fusion Protein that Synergizes with Oxaliplatin for Treatment of Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice

Free
Barbara Ziffels, Marco Stringhini, Philipp Probst, Tim Fugmann, Theo Sturm, Dario Neri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (9): 1544–1554.
https://doi.org/10.1158/1535-7163.MCT-18-1301
Published: 03 September 2019
View article titled, Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice
Open the PDF for Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice in another window
Includes: Supplementary data
Journal Articles

Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy

Free
Roberto De Luca, Alex Soltermann, Francesca Pretto, Catherine Pemberton-Ross, Giovanni Pellegrini, Sarah Wulhfard, Dario Neri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (11): 2442–2451.
https://doi.org/10.1158/1535-7163.MCT-17-0211
Published: 01 November 2017
View article titled, Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy
Open the PDF for Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy in another window
Includes: Supplementary data
Journal Articles

Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma

Free
Samuele Cazzamalli, Alberto Dal Corso, Dario Neri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (12): 2926–2935.
https://doi.org/10.1158/1535-7163.MCT-16-0283
Published: 01 December 2016
View article titled, Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma
Open the PDF for Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody–Drug Conjugates

Free
Rémy Gébleux, Sarah Wulhfard, Giulio Casi, Dario Neri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (11): 2606–2612.
https://doi.org/10.1158/1535-7163.MCT-15-0480
Published: 03 November 2015
View article titled, Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody–Drug Conjugates
Open the PDF for Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody–Drug Conjugates in another window
Includes: Supplementary data
Journal Articles

A Chemically Defined Trifunctional Antibody–Cytokine–Drug Conjugate with Potent Antitumor Activity

Free
Thomas List, Giulio Casi, Dario Neri
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2014) 13 (11): 2641–2652.
https://doi.org/10.1158/1535-7163.MCT-14-0599
Published: 03 November 2014
View article titled, A Chemically Defined Trifunctional Antibody–Cytokine–Drug Conjugate with Potent Antitumor Activity
Open the PDF for A Chemically Defined Trifunctional Antibody–Cytokine–Drug Conjugate with Potent Antitumor Activity in another window
Includes: Supplementary data
Journal Articles

Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice

Free
Katrin L. Gutbrodt, Giulio Casi, Dario Neri
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (7): 1772–1776.
https://doi.org/10.1158/1535-7163.MCT-14-0105
Published: 06 July 2014
View article titled, Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice
Open the PDF for Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice in another window
Journal Articles

Abstract B55: Phase I/II study of the tumor‐targeting human L19TNF‐monoclonal antibody‐cytokine fusion protein in patients with advanced solid tumors

Free
Gianluca Spitaleri, Tommaso M. De Pas, Cristina Noberasco, Leonardo Giovannoni, Hans D. Menseen, Luciano Zardi, Francesca Toffalorio, Chiara Catania, Alessandra Milani, Sabrina Boselli, Dario Neri, Filippo de Braud
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B55.
https://doi.org/10.1158/1535-7163.TARG-09-B55
Published: 10 December 2009
View article titled, Abstract B55: Phase I/II study of the tumor‐targeting human L19TNF‐monoclonal antibody‐cytokine fusion protein in patients with advanced solid tumors